InvestorsHub Logo
Followers 11
Posts 746
Boards Moderated 0
Alias Born 09/21/2017

Re: None

Wednesday, 11/22/2017 3:28:24 PM

Wednesday, November 22, 2017 3:28:24 PM

Post# of 106834
http://us-stemcell.com/ceo-blog-november-2017-preparing-for-year-end-and-a-productive-2018/

CEO Blog: November 2017 Preparing for Year-End and a Productive 2018

Posted by U.S. Stem Cell, Inc
Dear Shareholders and Friends,

We are pleased to share with you highlights of our latest key milestones, as we prepare for year-end and the start of a productive 2018.

Our sixth-straight successful period of positive financial results continued in the 3rd quarter of 2017, including a revenue increase of 106 percent from the same quarter last year. Net increase in gross profit also rose 102 percent, while cash from operations for the nine months ended Sept. 30 increased 1004% from negative $113k in 2016 to more than $1m in 2017.

This quarter, we also announced the opening of a new clinic in West Palm Beach, Florida, bringing the number of clinics using our technology to 287. Our venture at Regenerative Wellness Clinic with Dr. Rosemary Daly, who will be utilizing U.S. Stem Cell’s proprietary technology for pain management and other therapeutics, is evidence of the continued expansion of our clinical distribution platform.

Opportunities in our five revenue centers — clinics, physician training and certification, stem cell processing kits, veterinarian training and kit sales and stem cell banking — continue to expand each year, as we make stem cell treatments available to more and more customers worldwide, with more than 700 USRM certified stem cell physicians globally.

On October 13th, our Chief Science Officer Dr. Kristin Comella presented for a second year at Bulletproof’s 5th Annual Biohacking Conference in Pasadena. Dr. Comella participated in an informational Stem Cell Panel, led by stem cell therapy expert Harry Adelson, ND. Bulletproof’s founder Dave Asprey, an avid, Stem-Cell advocate, invited Dr. Comella to present at the conference after he received a successful stem cell procedure at a U.S. Stem Cell clinic. Mr. Asprey received stem cell injections for brain health and sexual function.

U.S. Stem Cell Clinic also recently treated top fitness expert Ben Greenfield. You can watch his procedure here: https://www.facebook.com/BGFitness/videos/10156434268379179/

We’re also excited to announce the publication of a new study by Dr. Comella titled “Safety Analysis of Autologous Stem Cell Therapy in a Variety of Degenerative Diseases and Injuries Using the Stromal Vascular Fraction” in the prestigious Journal of Clinical Medical Research.

The study shows the efficacy and safety of autologous stem cell therapy in individuals with degenerative diseases and injuries, and is a treatment that’s helping to change people’s lives.

Dr. Comella will also be presenting this November at the 15th Annual Meeting of the International Federation for Adipose Therapeutics and Science (IFATS) from November 30 to December 3, 2017 in South Beach, Miami. She’ll discuss her paper, “Effects of the Intradiscal Implantation of Stromal Vascular Fraction Plus Platelet Rich Plasma in Patients With Degenerative Disc Disease.” Patients demonstrated a statistically significant improvement in range of motion, pain reduction and quality of life, with no severe adverse events linked to the therapy. A link to the paper can be found here: http://bit.ly/2yDd33l

Finally, as you may know, we have issued a response to the FDA’s warning letter to US Stem Cell Clinic. We have engaged a large Washington, D.C. law firm who specializes in FDA case law to assist in our communications. We are having open communications with the agency and look forward to their responses.

We are committed to preserving the rights of patients to harness their bodies’ own healing potential. Our dedication to this emerging science is unwavering and we will continue to expand efforts to help patients maximize their health with this amazing technology.

We thank you for your interest and continued support.

Warmest regards,

Mike Tomas,

President and CEO